If someone told you that you could have longer, fuller lashes without mascara, would you believe them? Latisse, the first federally approved prescription drug for lengthening eyelashes, will be introduced to the general population at the end of the month. What consumers should know, however, is that Latisse is actually made of the same formula as Lumigan which is a prescription eye drop for glaucoma. Lash lengthening just happens to be a side effect.
If you seem wary of using a product that is being commercially manufactured for two separate reasons, one being for a side effect of the first, take into consideration the $600 million spent on Botox in 2007. Botox was actually produced first to treat muscular spasms because it freezes the muscles. The fact that this could be applied to your forehead to treat wrinkles, well, that’s just a welcome side effect.
The question of whether or not to use Latisse involves your weighing the pros and cons of the side effects of the side effect. These can include red, itchy eyes, changes in your eyelid coloring, and changes in your iris pigmentation. At a price of about $120 a month for the drug, your financial priorities should also be considered (hello, recession?).
Now that all the unbiased information is out of the way, I think I’ll be picking some of this up next month. Call it the easy way out, but when don’t come running when my lashes can beat up your lashes.
Disclosure: All products were provided for review. No monetary compensation was received for this review. All opinions belong to the author.
